Mesothelial cells in tissue repair and fibrosis

Frontiers in Pharmacology

Volumn 6, Issue MAY, 2015, Pages

  Mutsaers, Steven E ^a,b   Birnie, Kimberly ^b   Lansley, Sally ^b   Herrick, Sarah E ^c   Lim, Chuan Bian ^a,b   Prêle, Cecilia M ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Coagulation and fibrinolysis; Extracellular matrix; Idiopathic pulmonary fibrosis; Inflammation; Mesothelial to mesenchymal transition; Post operative adhesion; Tissue repair and fibrosis

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; FIBRIN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; SCLEROPROTEIN; THROMBIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; UROKINASE RECEPTOR;

CELL MIGRATION; CELL TRACKING; CYTOKINE PRODUCTION; EPITHELIAL MESENCHYMAL TRANSITION; FIBRINOLYSIS; FIBROGENESIS; FIBROSING ALVEOLITIS; HUMAN; INFLAMMATION; LUNG FIBROSIS; MESOTHELIUM CELL; NONHUMAN; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PLEURAL FIBROSIS; REVIEW; SEROSA; SIGNAL TRANSDUCTION; TISSUE ADHESION; TISSUE DIFFERENTIATION; TISSUE INJURY; TISSUE METABOLISM; TISSUE REPAIR;

EID: 84930682226     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00113     Document Type: Review

References (205)

1. Alonso Jde, M., Alves, A.L., Watanabe, M.J., Rodrigues, C.A., and Hussni, C.A. (2014). Peritoneal response to abdominal surgery: the role of equine abdominal adhesions and current prophylactic strategies. Vet Med Int 2014, 279730. doi: 10.1155/2014/279730.
2. Aroeira, L.S., Aguilera, A., Sanchez-Tomero, J.A., Bajo, M.A., Del Peso, G., Jimenez-Heffernan, J.A., Selgas, R., and Lopez-Cabrera, M. (2007). Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 18, 2004-2013. doi: 10.1681/ASN.2006111292.
3. Asahina, K., Zhou, B., Pu, W.T., and Tsukamoto, H. (2011). Septum transversum597 derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology 53, 983-995. doi: 10.1002/hep.24119.
4. Asano, T., Takazawa, R., Yamato, M., Takagi, R., Iimura, Y., Masuda, H., Kihara, K., and Okano, T. (2006). Transplantation of an autologous mesothelial cell sheet prepared from tunica vaginalis prevents post-operative adhesions in a canine model. Tissue Eng 12, 2629-2637. doi: 10.1089/ten.2006.12.2629.
5. Attard, J.A., and Maclean, A.R. (2007). Adhesive small bowel obstruction: epidemiology, biology and prevention. Can J Surg 50, 291-300.
6. Avsar, F.M., Sahin, M., Aksoy, F., Avsar, A.F., Akoz, M., Hengirmen, S., and Bilici, S. (2001). Effects of diphenhydramine HCl and methylprednisolone in the prevention of abdominal adhesions. Am J Surg 181, 512-515.
7. Baer, A.N., and Green, F.A. (1993). Cyclooxygenase activity of cultured human mesothelial cells. Prostaglandins 46, 37-49.
8. Bajaj, M.S., Pendurthi, U., Koenig, K., Pueblitz, S., and Idell, S. (2000). Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells. Eur Respir J 15, 1069-1078.
9. Bajo, M.A., Selgas, R., Castro, M.A., Del Peso, G., Diaz, C., Sanchez-Tomero, J.A., Fernandez De Castro, M., Alvarez, V., and Corbi, A. (2000). Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo. Perit Dial Int 20, 742-747.
10. Barber, N.A., and Ganti, A.K. (2011). Pulmonary toxicities from targeted therapies: a review. Target Oncol 6, 235-243. doi: 10.1007/s11523-011-0199-0.
11. Baroni, G., Schuinski, A., De Moraes, T.P., Meyer, F., and Pecoits-Filho, R. (2012). Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis. Mediators Inflamm. 2012;2012:912595. doi: 10.1155/2012/912595. Epub 2012 Mar 25.
12. Batra, H., and Antony, V.B. (2014). The pleural mesothelium in development and disease. Front Physiol 5, 284. doi: 10.3389/fphys.2014.00284.
13. Bergh, N.P., Ekroth, R., Larsson, S., and Nagy, P. (1977). Intrapleural streptokinase in the treatment of haemothorax and empyema. Scand J Thorac Cardiovasc Surg 11, 265-268.
14. Bertram, P., Tietze, L., Hoopmann, M., Treutner, K.H., Mittermayer, C., and Schumpelick, V. (1999). Intraperitoneal transplantation of isologous mesothelial cells for prevention of adhesions. Eur J Surg 165, 705-709. doi: 10.1080/11024159950189780.
15. Binda, M.M., Corona, R., Amant, F., and Koninckx, P.R. (2014). Conditioning of the abdominal cavity reduces tumor implantation in a laparoscopic mouse model. Surg Today 44, 1328-1335. doi: 10.1007/s00595-014-0832-5.
16. Boland, G.M., and Weigel, R.J. (2006). Formation and prevention of postoperative abdominal adhesions. J Surg Res 132, 3-12. doi: 10.1016/j.jss.2005.12.002.
17. Bottles, K.D., Laszik, Z., Morrissey, J.H., and Kinasewitz, G.T. (1997). Tissue factor expression in mesothelial cells: induction both in vivo and in vitro. Am J Respir Cell Mol Biol 17, 164-172.
18. Bouros, D., Schiza, S., Patsourakis, G., Chalkiadakis, G., Panagou, P., and Siafakas, N.M. (1997). Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med 155, 291-295. doi: 10.1164/ajrccm.155.1.9001327.
19. Brochhausen, C., Schmitt, V.H., Planck, C.N., Rajab, T.K., Hollemann, D., Tapprich, C., Kramer, B., Wallwiener, C., Hierlemann, H., Zehbe, R., Planck, H., and Kirkpatrick, C.J. (2012a). Current strategies and future perspectives for intraperitoneal adhesion prevention. J Gastrointest Surg 16, 1256-1274. doi: 10.1007/s11605-011-1819-9.
20. Brochhausen, C., Schmitt, V.H., Rajab, T.K., Planck, C.N., Kramer, B., Tapprich, C., Wallwiener, M., Hierlemann, H., Planck, H., and Kirkpatrick, C.J. (2012b). Mesothelial morphology and organisation after peritoneal treatment with solid and liquid adhesion barriers-a scanning electron microscopical study. J Mater Sci Mater Med 23, 1931-1939. doi: 10.1007/s10856-012-4659-6.
21. Cai, C.L., Martin, J.C., Sun, Y., Cui, L., Wang, L., Ouyang, K., Yang, L., Bu, L., Liang, X., Zhang, X., Stallcup, W.B., Denton, C.P., Mcculloch, A., Chen, J., and Evans, S.M. (2008). A myocardial lineage derives from Tbx18 epicardial cells. Nature 454, 104-108. doi: 10.1038/nature06969.
22. Cannistra, S.A., Ottensmeier, C., Tidy, J., and Defranzo, B. (1994). Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes. Exp Hematol 22, 996-1002.
23. Chen, L.J., Ye, H., Zhang, Q., Li, F.Z., Song, L.J., Yang, J., Mu, Q., Rao, S.S., Cai, P.C., Xiang, F., Zhang, J.C., Su, Y., Xin, J.B., and Ma, W.L. (2015). Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells. Toxicol Appl Pharmacol 283, 75-82. doi: 10.1016/j.taap.2015.01.004.
24. Chin, N.K., and Lim, T.K. (1997). Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 111, 275-279.
25. Ciszewicz, M., Wu, G., Tam, P., Polubinska, A., and Breborowicz, A. (2007). Changes in peritoneal mesothelial cells phenotype after chronic exposure to glucose or N-acetylglucosamine. Transl Res. 2007 Dec;150(6):337-42. Epub 2007 Aug 15.
26. Colice, G.L., Curtis, A., Deslauriers, J., Heffner, J., Light, R., Littenberg, B., Sahn, S., Weinstein, R.A., and Yusen, R.D. (2000). Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 118, 1158-1171.
27. Combet, S., Miyata, T., Moulin, P., Pouthier, D., Goffin, E., and Devuyst, O. (2000). Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol. 2000 Apr;11(4):717-28.
28. Dai, T., Wang, Y., Nayak, A., Nast, C.C., Quang, L., Lapage, J., Andalibi, A., and Adler, S.G. (2014). Janus kinase signaling activation mediates peritoneal inflammation and injury in vitro and in vivo in response to dialysate. Kidney Int.
29. Dail, D.H., and Hammar, S.P. (1994). Pulmonary Pathology. New York: Springer.
30. De Vriese, A.S., Tilton, R.G., Mortier, S., and Lameire, N.H. (2006). Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant. 2006 Sep;21(9):2549-55. Epub 2006 Jun 6.
31. Decologne, N., Kolb, M., Margetts, P.J., Menetrier, F., Artur, Y., Garrido, C., Gauldie, J., Camus, P., and Bonniaud, P. (2007). TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol 179, 6043-6051.
32. Devuyst, O., Topley, N., and Williams, J.D. (2002). Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions. Nephrol Dial Transplant. 2002;17 Suppl 3:12-5.
33. Di Paolo, N., Sacchi, G., De Mia, M., Gaggiotti, E., Capotondo, L., Rossi, P., Bernini, M., Pucci, A.M., Ibba, L., Sabatelli, P., and et al. (1986). Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron. 1986;44(3):204-11.
34. Di Paolo, N., Sacchi, G., Vanni, L., Corazzi, S., Terrana, B., Rossi, P., Gaggiotti, E., and Buoncristiani, U. (1991). Autologous peritoneal mesothelial cell implant in rabbits and peritoneal dialysis patients. Nephron 57, 323-331.
35. Dioszeghy, V., Rosas, M., Maskrey, B.H., Colmont, C., Topley, N., Chaitidis, P., Kuhn, H., Jones, S.A., Taylor, P.R., and O'donnell, V.B. (2008). 12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo. J Immunol. 2008 Nov 1;181(9):6514-24.
36. Dixit, R., Ai, X., and Fine, A. (2013). Derivation of lung mesenchymal lineages from the fetal mesothelium requires hedgehog signaling for mesothelial cell entry. Development 140, 4398-4406. doi: 10.1242/dev.098079.
37. Dizerega, G.S., and Campeau, J.D. (2001). Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update 7, 547-555.
38. Dobbie, J.W., and Jasani, M.K. (1997). Role of imbalance of intracavity fibrin formation and removal in the pathogenesis of peritoneal lesions in CAPD. Perit Dial Int 17, 121-124.
39. Dorr, P.J., Vemer, H.M., Brommer, E.J., Willemsen, W.N., Veldhuizen, R.W., and Rolland, R. (1990). Prevention of postoperative adhesions by tissue-type plasminogen activator (t-PA) in the rabbit. Eur J Obstet Gynecol Reprod Biol 37, 287-291.
40. Drake, T.A., Morrissey, J.H., and Edgington, T.S. (1989). Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134, 1087-1097.
41. Ellis, H. (1997). The clinical significance of adhesions: focus on intestinal obstruction. Eur J Surg Suppl, 5-9.
42. Fang, C.C., Yen, C.J., Chen, Y.M., Chu, T.S., Lin, M.T., Yang, J.Y., and Tsai, T.J. (2006). Diltiazem suppresses collagen synthesis and IL-1beta-induced TGF728 beta1 production on human peritoneal mesothelial cells. Nephrol Dial Transplant 21, 1340-1347. doi: 10.1093/ndt/gfk051.
43. Foley-Comer, A.J., Herrick, S.E., Al-Mishlab, T., Prele, C.M., Laurent, G.J., and Mutsaers, S.E. (2002). Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci 115, 1383-1389.
44. Garosi, G., and Di Paolo, N. (2000). Pathophysiology and morphological clinical correlation in experimental and peritoneal dialysis-induced peritoneal sclerosis. Adv Perit Dial. 2000;16:204-7.
45. Garosi, G., and Di Paolo, N. (2001). Morphological aspects of peritoneal sclerosis. J Nephrol. 2001 Nov-Dec;14 Suppl 4:S30-8.
46. Gorvy, D.A., Herrick, S.E., Shah, M., and Ferguson, M.W. (2005). Experimental manipulation of transforming growth factor-beta isoforms significantly affects adhesion formation in a murine surgical model. Am J Pathol 167, 1005-1019.
47. Greenhalgh, S.N., Iredale, J.P., and Henderson, N.C. (2013). Origins of fibrosis: pericytes take centre stage. F1000Prime Rep 5, 37. doi: 10.12703/P5-37.
48. Haslinger, B., Kleemann, R., Toet, K.H., and Kooistra, T. (2003). Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. Kidney Int 63, 2065-2074. doi: 10.1046/j.1523-1755.2003.t01-2-00004.x.
49. Haslinger, B., Mandl-Weber, S., Sellmayer, A., and Sitter, T. (2001). Hyaluronan fragments induce the synthesis of MCP-1 and IL-8 in cultured human peritoneal mesothelial cells. Cell Tissue Res. 2001 Jul;305(1):79-86.
50. Hekking, L.H., Harvey, V.S., Havenith, C.E., Van Den Born, J., Beelen, R.H., Jackman, R.W., and Nagy, J.A. (2003). Mesothelial cell transplantation in models of acute inflammation and chronic peritoneal dialysis. Perit Dial Int 23, 323-330.
51. Hekking, L.H., Zweers, M.M., Keuning, E.D., Driesprong, B.A., De Waart, D.R., Beelen, R.H., and Van Den Born, J. (2005). Apparent successful mesothelial cell transplantation hampered by peritoneal activation. Kidney Int 68, 2362-2367. doi: 10.1111/j.1523-1755.2005.00698.x.
52. Higazi, A.A., Bdeir, K., Hiss, E., Arad, S., Kuo, A., Barghouti, I., and Cines, D.B. (1998). Lysis of plasma clots by urokinase-soluble urokinase receptor complexes. Blood 92, 2075-2083.
53. Hinz, B., Phan, S.H., Thannickal, V.J., Galli, A., Bochaton-Piallat, M.L., and Gabbiani, G. (2007). The myofibroblast: one function, multiple origins. Am J Pathol 170, 1807-1816. doi: 10.2353/ajpath.2007.070112.
54. Huggins, J.T., and Sahn, S.A. (2004). Causes and management of pleural fibrosis. Respirology 9, 441-447. doi: 10.1111/j.1440-1843.2004.00630.x.
55. Hung, K.Y., Chen, C.T., Huang, J.W., Lee, P.H., Tsai, T.J., and Hsieh, B.S. (2001). Dipyridamole inhibits TGF-beta-induced collagen gene expression in human peritoneal mesothelial cells. Kidney Int 60, 1249-1257. doi: 10.1046/j.1523-1755.2001.00933.x.
56. Hung, K.Y., Huang, J.W., Chen, C.T., Lee, P.H., and Tsai, T.J. (2003). Pentoxifylline modulates intracellular signalling of TGF-beta in cultured human peritoneal mesothelial cells: implications for prevention of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 18, 670-676.
57. Idell, S. (1995). "Coagulation, Fibrinolysis and Fibrin Deposition in Lung Injury and Repair, "in Pulmonary Fibrosis, ed. P.S.a. T. Rs. (New York: Marcel Dekker), 743-776.
58. Idell, S. (2008). The pathogenesis of pleural space loculation and fibrosis. Curr Opin Pulm Med 14, 310-315. doi: 10.1097/MCP.0b013e3282fd0d9b.
59. Idell, S., Girard, W., Koenig, K.B., Mclarty, J., and Fair, D.S. (1991). Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 144, 187-194. doi: 10.1164/ajrccm/144.1.187.
60. Idell, S., Mazar, A., Cines, D., Kuo, A., Parry, G., Gawlak, S., Juarez, J., Koenig, K., Azghani, A., Hadden, W., Mclarty, J., and Miller, E. (2002). Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits. Am J Respir Crit Care Med 166, 920-926. doi: 10.1164/rccm.200204-313OC.
61. Idell, S., Mazar, A.P., Bitterman, P., Mohla, S., and Harabin, A.L. (2001). Fibrin turnover in lung inflammation and neoplasia. Am J Respir Crit Care Med 163, 578-584. doi: 10.1164/ajrccm.163.2.2005135.
62. Idell, S., Pendurthi, U., Pueblitz, S., Koenig, K., Williams, T., and Rao, L.V. (1998). Tissue factor pathway inhibitor in tetracycline-induced pleuritis in rabbits. Thromb Haemost 79, 649-655.
63. Idell, S., Zwieb, C., Kumar, A., Koenig, K.B., and Johnson, A.R. (1992). Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 7, 414-426. doi: 10.1165/ajrcmb/7.4.414.
64. Iozzo, R.V. (2005). Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol. 2005 Aug;6(8):646-56.
65. Irkorucu, O., Ferahkose, Z., Memis, L., Ekinci, O., and Akin, M. (2009). Reduction of postsurgical adhesions in a rat model: a comparative study. Clinics (Sao Paulo) 64, 143-148.
66. Isaksson, K., Montgomery, A., Moberg, A.C., Andersson, R., and Tingstedt, B. (2014). Long-term follow-up for adhesive small bowel obstruction after open versus laparoscopic surgery for suspected appendicitis. Ann Surg 259, 1173-1177. doi: 10.1097/SLA.0000000000000322.
67. Ivarsson, M.L., Holmdahl, L., Falk, P., Molne, J., and Risberg, B. (1998). Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 58, 195-203.
68. Jang, Y.H., Shin, H.S., Sun Choi, H., Ryu, E.S., Jin Kim, M., Ki Min, S., Lee, J.H., Kook Lee, H., Kim, K.H., and Kang, D.H. (2013). Effects of dexamethasone on the TGF-beta1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells. Lab Invest 93, 194-206. doi: 10.1038/labinvest.2012.166.
69. Jantz, M.A., and Antony, V.B. (2008). Pathophysiology of the pleura. Respiration 75, 121-133. doi: 10.1159/000113629.
70. Jonjic, N., Peri, G., Bernasconi, S., Sciacca, F.L., Colotta, F., Pelicci, P., Lanfrancone, L., and Mantovani, A. (1992). Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 176, 1165-1174.
71. Kamp, D.W., and Weitzman, S.A. (1999). The molecular basis of asbestos induced lung injury. Thorax 54, 638-652.
72. Karki, S., Surolia, R., Hock, T.D., Guroji, P., Zolak, J.S., Duggal, R., Ye, T., Thannickal, V.J., and Antony, V.B. (2014). Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis. FASEB J 28, 1122-1131. doi: 10.1096/fj.13-236828.
73. Kawaguchi, M., Bader, D.M., and Wilm, B. (2007). Serosal mesothelium retains vasculogenic potential. Dev Dyn 236, 2973-2979. doi: 10.1002/dvdy.21334.
74. Kawanishi, K., Yamato, M., Sakiyama, R., Okano, T., and Nitta, K. (2013). Peritoneal cell sheets composed of mesothelial cells and fibroblasts prevent intra-abdominal adhesion formation in a rat model. J Tissue Eng Regen Med. doi: 10.1002/term.1860.
75. Kement, M., Censur, Z., Oncel, M., Buyukokuroglu, M.E., and Gezen, F.C. (2011). Heparin for adhesion prevention: comparison of three different dosages with Seprafilm in a murine model. Int J Surg 9, 225-228. doi: 10.1016/j.ijsu.2010.11.016.
76. Kim, J.J., Li, J.J., Kim, K.S., Kwak, S.J., Jung, D.S., Ryu, D.R., Yoo, T.H., Choi, H.Y., Han, S.H., Kim, H.J., Yoon, S.Y., Han, D.S., and Kang, S.W. (2008). High glucose decreases collagenase expression and increases TIMP expression in cultured human peritoneal mesothelial cells. Nephrol Dial Transplant. 2008 Feb;23(2):534-41. Epub 2007 Nov 23.
77. Kim, Y.D., Jun, Y.J., Kim, J., and Kim, C.K. (2014). Effects of human adipose843 derived stem cells on the regeneration of damaged visceral pleural mesothelial cells: a morphological study in a rabbit model. Interact Cardiovasc Thorac Surg 19, 363-367. doi: 10.1093/icvts/ivu124.
78. Kinashi, H., Ito, Y., Mizuno, M., Suzuki, Y., Terabayashi, T., Nagura, F., Hattori, R., Matsukawa, Y., Mizuno, T., Noda, Y., Nishimura, H., Nishio, R., Maruyama, S., Imai, E., Matsuo, S., and Takei, Y. (2013). TGF-beta1 promotes lymphangiogenesis during peritoneal fibrosis. J Am Soc Nephrol. 2013 Oct;24(10):1627-42. doi: 10.1681/ASN.2012030226. Epub 2013 Aug 29.
79. King, T.E., Jr., Bradford, W.Z., Castro-Bernardini, S., Fagan, E.A., Glaspole, I., Glassberg, M.K., Gorina, E., Hopkins, P.M., Kardatzke, D., Lancaster, L., Lederer, D.J., Nathan, S.D., Pereira, C.A., Sahn, S.A., Sussman, R., Swigris, J.J., Noble, P.W., and Group, A.S. (2014). A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370, 2083-2092. doi: 10.1056/NEJMoa1402582.
80. Kiribayashi, K., Masaki, T., Naito, T., Ogawa, T., Ito, T., Yorioka, N., and Kohno, N. (2005). Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1/2 and p38 MAPK. Kidney Int 67, 1126-1135. doi: 10.1111/j.1523-1755.2005.00179.x.
81. Kitamura, S., Horimoto, N., Tsuji, K., Inoue, A., Takiue, K., Sugiyama, H., and Makino, H. (2014). The selection of peritoneal mesothelial cells is important for cell therapy to prevent peritoneal fibrosis. Tissue Eng Part A 20, 529-539. doi: 10.1089/ten. TEA.2013.0130.
82. Kuhn, C., and Mcdonald, J.A. (1991). The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 138, 1257-1265.
83. Kutlay, J., Ozer, Y., Isik, B., and Kargici, H. (2004). Comparative effectiveness of several agents for preventing postoperative adhesions. World J Surg 28, 662-665. doi: 10.1007/s00268-004-6825-6.
84. Lachaud, C.C., Pezzolla, D., Dominguez-Rodriguez, A., Smani, T., Soria, B., and Hmadcha, A. (2013). Functional vascular smooth muscle-like cells derived from adult mouse uterine mesothelial cells. PLoS One 8, e55181. doi: 10.1371/journal.pone.0055181.
85. Lai, K.N., and Leung, J.C. (2010). Inflammation in peritoneal dialysis. Nephron Clin Pract. 2010;116(1):c11-8. doi: 10.1159/000314544. Epub 2010 May 12.
86. Lamouille, S., Subramanyam, D., Blelloch, R., and Derynck, R. (2013). Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell Biol 25, 200-207. doi: 10.1016/j.ceb.2013.01.008.
87. Lansley, S.M., Searles, R.G., Hoi, A., Thomas, C., Moneta, H., Herrick, S.E., Thompson, P.J., Newman, M., Sterrett, G.F., Prele, C.M., and Mutsaers, S.E. (2011). Mesothelial cell differentiation into osteoblast-and adipocyte-like cells. J Cell Mol Med 15, 2095-2105. doi: 10.1111/j.1582-4934.2010.01212.x.
88. Laurent, P., Magne, L., De Palmas, J., Bignon, J., and Jaurand, M.C. (1988). Quantitation of elastin in human urine and rat pleural mesothelial cell matrix by a sensitive avidin-biotin ELISA for desmosine. J Immunol Methods 107, 1-11.
89. Le Poole, C.Y., Welten, A.G., Weijmer, M.C., Valentijn, R.M., Van Ittersum, F.J., and Ter Wee, P.M. (2005). Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious. Perit Dial Int 25 Suppl 3, S64-68.
90. Lee, J.H., Go, A.K., Oh, S.H., Lee, K.E., and Yuk, S.H. (2005). Tissue anti-adhesion potential of ibuprofen-loaded PLLA-PEG diblock copolymer films. Biomaterials 26, 671-678. doi: 10.1016/j.biomaterials.2004.03.009.
91. Lee, S.H., Kang, H.Y., Kim, K.S., Nam, B.Y., Paeng, J., Kim, S., Li, J.J., Park, J.T., Kim, D.K., Han, S.H., Yoo, T.H., and Kang, S.W. (2012). The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelial cells. Lab Invest. 2012 Dec;92(12):1698-711. doi: 10.1038/labinvest.2012.132. Epub 2012 Sep 24.
92. Lee, Y.C., Baumann, M.H., Maskell, N.A., Waterer, G.W., Eaton, T.E., Davies, R.J., Heffner, J.E., and Light, R.W. (2003a). Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest 124, 2229-2238.
93. Lee, Y.C., and Lane, K.B. (2001). The many faces of transforming growth factor906 beta in pleural diseases. Curr Opin Pulm Med 7, 173-179.
94. Lee, Y.C., Lane, K.B., Parker, R.E., Ayo, D.S., Rogers, J.T., Diters, R.W., Thompson, P.J., and Light, R.W. (2000). Transforming growth factor beta(2) (TGF beta(2)) produces effective pleurodesis in sheep with no systemic complications. Thorax 55, 1058-1062.
95. Lee, Y.C., Lane, K.B., Zoia, O., Thompson, P.J., Light, R.W., and Blackwell, T.S. (2003b). Transforming growth factor-beta induces collagen synthesis without inducing IL-8 production in mesothelial cells. Eur Respir J 22, 197-202.
96. Lee, Y.C., Tsai, Y.S., Hung, S.Y., Lin, T.M., Lin, S.H., Liou, H.H., Liu, H.C., Chang, M.Y., Wang, H.H., Ho, L.C., Chen, Y.T., Chen, H.P., Fan, H.A., Liu, K.W., Kung, Y.T., Wang, H.K., and Chiou, Y.Y. (2014). Shorter daily dwelling time in peritoneal dialysis attenuates the epithelial-to-mesenchymal transition of mesothelial cells. BMC Nephrol 15, 35. doi: 10.1186/1471-2369-15-35.
97. Li, Y., Wang, J., and Asahina, K. (2013). Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury. Proc Natl Acad Sci U S A 110, 2324-2329. doi: 10.1073/pnas.1214136110.
98. Liberek, T., Topley, N., Luttmann, W., and Williams, J.D. (1996). Adherence of neutrophils to human peritoneal mesothelial cells: role of intercellular adhesion molecule-1. J Am Soc Nephrol 7, 208-217.
99. Light, R. (2003). Update: management of parapneumonic effusions. Clin Pulm Med 10, 336-342.
100. Liu, H., Zhang, N., and Tian, D. (2014a). MiR-30b is involved in methylglyoxal929 induced epithelial-mesenchymal transition of peritoneal mesothelial cells in rats. Cell Mol Biol Lett 19, 315-329. doi: 10.2478/s11658-014-0199-z.
101. Liu, J., Zeng, L., Zhao, Y., Zhu, B., Ren, W., and Wu, C. (2014b). Selenium suppresses lipopolysaccharide-induced fibrosis in peritoneal mesothelial cells through inhibition of epithelial-to-mesenchymal transition. Biol Trace Elem Res 161, 202-209. doi: 10.1007/s12011-014-0091-8.
102. Liu, Q., Mao, H., Nie, J., Chen, W., Yang, Q., Dong, X., and Yu, X. (2008). Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells. Perit Dial Int 28 Suppl 3, S88-95.
103. Liu, X.X., Zhou, H.J., Cai, L., Zhang, W., Ma, J.L., Tao, X.J., and Yu, J.N. (2012). NADPH oxidase-dependent formation of reactive oxygen species contributes to transforming growth factor beta1-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells, and the role of astragalus intervention. Chin J Integr Med. 2012 Oct 22.
104. López-Cabrera, M. (2014). Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis. Advances in Medicine 2014, 17 pages. doi: http://dx.doi.org/10.1155/2014/473134.
105. Ma, C., Tarnuzzer, R.W., and Chegini, N. (1999). Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1. Wound Repair Regen 7, 477-485.
106. Madri, J.A., and Furthmayr, H. (1980). Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis. Hum Pathol 11, 353-366.
107. Margetts, P.J., Bonniaud, P., Liu, L., Hoff, C.M., Holmes, C.J., West-Mays, J.A., and Kelly, M.M. (2005). Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 16, 425-436. doi: 10.1681/ASN.2004060436.
108. Margetts, P.J., Gyorffy, S., Kolb, M., Yu, L., Hoff, C.M., Holmes, C.J., and Gauldie, J. (2002a). Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 13, 721-728.
109. Margetts, P.J., Hoff, C., Liu, L., Korstanje, R., Walkin, L., Summers, A., Herrick, S., and Brenchley, P. (2013). Transforming growth factor beta-induced peritoneal fibrosis is mouse strain dependent. Nephrol Dial Transplant 28, 2015-2027. doi: 10.1093/ndt/gfs289.
110. Margetts, P.J., Kolb, M., Yu, L., Hoff, C.M., Holmes, C.J., Anthony, D.C., and Gauldie, J. (2002b). Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol. 2002 Jun;160(6):2285-94.
111. Massague, J. (1996). TGFbeta signaling: receptors, transducers, and Mad proteins. Cell 85, 947-950.
112. Mateijsen, M.A., Van Der Wal, A.C., Hendriks, P.M., Zweers, M.M., Mulder, J., Struijk, D.G., and Krediet, R.T. (1999). Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int. 1999 Nov-Dec;19(6):517-25.
113. Mcloughlin, R.M., Hurst, S.M., Nowell, M.A., Harris, D.A., Horiuchi, S., Morgan, L.W., Wilkinson, T.S., Yamamoto, N., Topley, N., and Jones, S.A. (2004). Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. J Immunol. 2004 May 1;172(9):5676-83.
114. Meltzer, E.B., and Noble, P.W. (2008). Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 3, 8. doi: 10.1186/1750-1172-3-8.
115. Miller, E.J., Kajikawa, O., Pueblitz, S., Light, R.W., Koenig, K.K., and Idell, S. (1999). Chemokine involvement in tetracycline-induced pleuritis. Eur Respir J 14, 1387-1393.
116. Milligan, S.A., Owens, M.W., Henderson, R.J., Jr., and Grimes, S.R., Jr. (1995). Characterization of proteoglycans produced by rat pleural mesothelial cells in vitro. Exp Lung Res 21, 559-575.
117. Molinas, C.R., and Koninckx, P.R. (2000). Hypoxaemia induced by CO(2) or helium pneumoperitoneum is a co-factor in adhesion formation in rabbits. Hum Reprod 15, 1758-1763.
118. Mutsaers, S.E. (2002). Mesothelial cells: their structure, function and role in serosal repair. Respirology 7, 171-191.
119. Mutsaers, S.E., Prele, C.M., Brody, A.R., and Idell, S. (2004). Pathogenesis of pleural fibrosis. Respirology 9, 428-440. doi: 10.1111/j.1440-1843.2004.00633.x.
120. Mutsaers, S.E., and Wilkosz, S. (2007). Structure and function of mesothelial cells. Cancer Treat Res 134, 1-19.
121. Nagy, J.A., Shockley, T.R., Masse, E.M., Harvey, V.S., Hoff, C.M., and Jackman, R.W. (1995). Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface. Gene Ther 2, 402-410.
122. Nasreen, N., Mohammed, K.A., Mubarak, K.K., Baz, M.A., Akindipe, O.A., Fernandez-Bussy, S., and Antony, V.B. (2009). Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol 297, L115-124. doi: 10.1152/ajplung.90587.2008.
123. Nicholson, A.G., Colby, T.V., Du Bois, R.M., Hansell, D.M., and Wells, A.U. (2000). The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162, 2213-2217. doi: 10.1164/ajrccm.162.6.2003049.
124. Noh, H., Ha, H., Yu, M.R., Kim, Y.O., Kim, J.H., and Lee, H.B. (2005). Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species. Perit Dial Int 25, 38-47.
125. O'donoghue, R.J., Knight, D.A., Richards, C.D., Prele, C.M., Lau, H.L., Jarnicki, A.G., Jones, J., Bozinovski, S., Vlahos, R., Thiem, S., Mckenzie, B.S., Wang, B., Stumbles, P., Laurent, G.J., Mcanulty, R.J., Rose-John, S., Zhu, H.J., Anderson, G.P., Ernst, M.R., and Mutsaers, S.E. (2012). Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol Med 4, 939-951. doi: 10.1002/emmm.201100604.
126. Oh, S.H., Kim, J.K., Song, K.S., Noh, S.M., Ghil, S.H., Yuk, S.H., and Lee, J.H. (2005). Prevention of postsurgical tissue adhesion by anti-inflammatory drug-loaded pluronic mixtures with sol-gel transition behavior. J Biomed Mater Res A 72, 306-316. doi: 10.1002/jbm.a.30239.
127. Osada, S., Hamada, C., Shimaoka, T., Kaneko, K., Horikoshi, S., and Tomino, Y. (2009). Alterations in proteoglycan components and histopathology of the peritoneum in uraemic and peritoneal dialysis (PD) patients. Nephrol Dial Transplant. 2009 Nov;24(11):3504-12. doi: 10.1093/ndt/gfp268. Epub 2009 Jun 19.
128. Ott, D.E. (2001). Laparoscopy and tribology: the effect of laparoscopic gas on peritoneal fluid. J Am Assoc Gynecol Laparosc 8, 117-123.
129. Owens, M.W., and Grimes, S.R. (1993). Pleural mesothelial cell response to inflammation: tumor necrosis factor-induced mitogenesis and collagen synthesis. Am J Physiol 265, L382-388.
130. Owens, M.W., and Milligan, S.A. (1994). Growth factor modulation of rat pleural mesothelial cell mitogenesis and collagen synthesis. Effects of epidermal growth factor and platelet-derived factor. Inflammation 18, 77-87.
131. Pados, G., Venetis, C.A., Almaloglou, K., and Tarlatzis, B.C. (2010). Prevention of intra-peritoneal adhesions in gynaecological surgery: theory and evidence. Reprod Biomed Online 21, 290-303. doi: 10.1016/j.rbmo.2010.04.021.
132. Palumbo-Zerr, K., Zerr, P., Distler, A., Fliehr, J., Mancuso, R., Huang, J., Mielenz, D., Tomcik, M., Furnrohr, B.G., Scholtysek, C., Dees, C., Beyer, C., Kronke, G., Metzger, D., Distler, O., Schett, G., and Distler, J.H. (2015). Orphan nuclear receptor NR4A1 regulates transforming growth factor-beta signaling and fibrosis. Nat Med 21, 150-158. doi: 10.1038/nm.3777.
133. Patel, P., Sekiguchi, Y., Oh, K.H., Patterson, S.E., Kolb, M.R., and Margetts, P.J. (2010a). Smad3-dependent and-independent pathways are involved in peritoneal membrane injury. Kidney Int 77, 319-328. doi: 10.1038/ki.2009.436.
134. Patel, P., West-Mays, J., Kolb, M., Rodrigues, J.C., Hoff, C.M., and Margetts, P.J. (2010b). Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells. Matrix Biol 29, 97-106. doi: 10.1016/j.matbio.2009.10.004.
135. Perez-Lozano, M.L., Sandoval, P., Rynne-Vidal, A., Aguilera, A., Jimenez-Heffernan, J.A., Albar-Vizcaino, P., Majano, P.L., Sanchez-Tomero, J.A., Selgas, R., and Lopez-Cabrera, M. (2013). Functional relevance of the switch of VEGF receptors/co-receptors during peritoneal dialysis-induced mesothelial to mesenchymal transition. PLoS One 8, e60776. doi: 10.1371/journal.pone.0060776.
136. Perfumo, F., Altieri, P., Degl'innocenti, M.L., Ghiggeri, G.M., Caridi, G., Trivelli, A., and Gusmano, R. (1996). Effects of peritoneal effluents on mesothelial cells in culture: cell proliferation and extracellular matrix regulation. Nephrol Dial Transplant 11, 1803-1809.
137. Perkins, R.C., Broaddus, V.C., Shetty, S., Hamilton, S., and Idell, S. (1999). Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells. Am J Respir Cell Mol Biol 21, 637-646. doi: 10.1165/ajrcmb.21.5.3225.
138. Phan, S.H. (2002). The myofibroblast in pulmonary fibrosis. Chest 122, 286S-289S.
139. Que, J., Wilm, B., Hasegawa, H., Wang, F., Bader, D., and Hogan, B.L. (2008). Mesothelium contributes to vascular smooth muscle and mesenchyme during lung development. Proc Natl Acad Sci U S A 105, 16626-16630. doi: 10.1073/pnas.0808649105.
140. Raghu, G., Collard, H.R., Egan, J.J., Martinez, F.J., Behr, J., Brown, K.K., Colby, T.V., Cordier, J.F., Flaherty, K.R., Lasky, J.A., Lynch, D.A., Ryu, J.H., Swigris, J.J., Wells, A.U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D.M., Johkoh, T., Kim, D.S., King, T.E., Jr., Kondoh, Y., Myers, J., Muller, N.L., Nicholson, A.G., Richeldi, L., Selman, M., Dudden, R.F., Griss, B.S., Protzko, S.L., Schunemann, H.J., and Fibrosis, A.E.J.a. C.O.I.P. (2011). An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183, 788-824. doi: 10.1164/rccm.2009-040GL.
141. Rajab, T.K., Wallwiener, M., Talukdar, S., and Kraemer, B. (2009). Adhesion1082 related complications are common, but rarely discussed in preoperative consent: a multicenter study. World J Surg 33, 748-750. doi: 10.1007/s00268-008-9917-x.
142. Rennard, S.I., Jaurand, M.C., Bignon, J., Kawanami, O., Ferrans, V.J., Davidson, J., and Crystal, R.G. (1984). Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am Rev Respir Dis 130, 267-274.
143. Richeldi, L., Du Bois, R.M., Raghu, G., Azuma, A., Brown, K.K., Costabel, U., Cottin, V., Flaherty, K.R., Hansell, D.M., Inoue, Y., Kim, D.S., Kolb, M., Nicholson, A.G., Noble, P.W., Selman, M., Taniguchi, H., Brun, M., Le Maulf, F., Girard, M., Stowasser, S., Schlenker-Herceg, R., Disse, B., Collard, H.R., and Investigators, I.T. (2014). Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370, 2071-2082. doi: 10.1056/NEJMoa1402584.
144. Rom, W.N. (1998a). "Asbestos-Related Diseases, "in Environmental and Occupational Medicine, ed. W.N. Rom. 3rd ed (Philadelphia: Lipincott-Raven), 349-357.
145. Rom, W.N. (1998b). "Silicates and Benign Pneumoconioses, "in Environmental and Occupational Medicine, ed. W.N. Rom. 3rd ed (Philadelphia: Lipincott-Raven), 587-599.
146. Rougier, J.P., Guia, S., Hagege, J., Nguyen, G., and Ronco, P.M. (1998). PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1. Kidney Int 54, 87-98. doi: 10.1046/j.1523-1755.1998.00955.x.
147. Sandoval, P., Loureiro, J., Gonzalez-Mateo, G., Perez-Lozano, M.L., Maldonado-Rodriguez, A., Sanchez-Tomero, J.A., Mendoza, L., Santamaria, B., Ortiz, A., Ruiz-Ortega, M., Selgas, R., Martin, P., Sanchez-Madrid, F., Aguilera, A., and Lopez-Cabrera, M. (2010). PPAR-gamma agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. Lab Invest 90, 1517-1532. doi: 10.1038/labinvest.2010.111.
148. Schlotterbeck, H., Greib, N., Dow, W.A., Schaeffer, R., Geny, B., and Diemunsch, P.A. (2011). Changes in core temperature during peritoneal insufflation: comparison of two CO2 humidification devices in pigs. J Surg Res 171, 427-432. doi: 10.1016/j.jss.2010.04.003.
149. Schneider, F., Gruden, J., Tazelaar, H.D., and Leslie, K.O. (2012). Pleuropulmonary pathology in patients with rheumatic disease. Arch Pathol Lab Med 136, 1242-1252. doi: 10.5858/arpa.2012-0248-SA.
150. Seiscento, M., Vargas, F.S., Antonangelo, L., Acencio, M.M., Bombarda, S., Capelozzi, V.L., and Teixeira, L.R. (2007). Transforming growth factor beta-1 as a predictor of fibrosis in tuberculous pleurisy. Respirology 12, 660-663. doi: 10.1111/j.1440-1843.2007.01135.x.
151. Sekiguchi, Y., Hamada, C., Ro, Y., Nakamoto, H., Inaba, M., Shimaoka, T., Io, H., Koyanagi, I., Aruga, S., Inuma, J., Kaneko, K., Hotta, Y., Margetts, P.J., Mochizuki, H., Horikoshi, S., and Tomino, Y. (2012). Differentiation of bone marrow-derived cells into regenerated mesothelial cells in peritoneal remodeling using a peritoneal fibrosis mouse model. J Artif Organs 15, 272-282. doi: 10.1007/s10047-012-0648-2.
152. Shetty, S., and Idell, S. (1998). A urokinase receptor mRNA binding protein from rabbit lung fibroblasts and mesothelial cells. Am J Physiol 274, L871-882.
153. Shetty, S., Kumar, A., Johnson, A., Pueblitz, S., and Idell, S. (1995a). Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis. Am J Physiol 268, L972-982.
154. Shetty, S., Kumar, A., Johnson, A.R., and Idell, S. (1995b). Regulation of mesothelial cell mitogenesis by antisense oligonucleotides for the urokinase receptor. Antisense Res Dev 5, 307-314.
155. Shetty, S., Padijnayayveetil, J., Tucker, T., Stankowska, D., and Idell, S. (2008). The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability. Am J Physiol Lung Cell Mol Physiol 295, L967-975. doi: 10.1152/ajplung.90349.2008.
156. Sitrin, R.G., Todd, R.F., 3rd, Albrecht, E., and Gyetko, M.R. (1996). The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 97, 1942-1951. doi: 10.1172/JCI118626.
157. Strange, C., Baumann, M.H., Sahn, S.A., and Idell, S. (1995). Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med 151, 508-515. doi: 10.1164/ajrccm.151.2.7842213.
158. Strippoli, R., Benedicto, I., Perez Lozano, M.L., Cerezo, A., Lopez-Cabrera, M., and Del Pozo, M.A. (2008). Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway. Dis Model Mech 1, 264-274. doi: 10.1242/dmm.001321.
159. Stylianou, E., Jenner, L.A., Davies, M., Coles, G.A., and Williams, J.D. (1990). Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 37, 1563-1570.
160. Sulaiman, H., Dawson, L., Laurent, G.J., Bellingan, G.J., and Herrick, S.E. (2002). Role of plasminogen activators in peritoneal adhesion formation. Biochem Soc Trans 30, 126-131. doi: 10.1042/.
161. Szeto, C.C., Chow, K.M., Poon, P., Szeto, C.Y., Wong, T.Y., and Li, P.K. (2004). Genetic polymorphism of VEGF: Impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients. Kidney Int. 2004 May;65(5):1947-55.
162. Takazawa, R., Yamato, M., Kageyama, Y., Okano, T., and Kihara, K. (2005). Mesothelial cell sheets cultured on fibrin gel prevent adhesion formation in an intestinal hernia model. Tissue Eng 11, 618-625. doi: 10.1089/ten.2005.11.618.
163. Thannickal, V.J., Toews, G.B., White, E.S., Lynch, J.P., 3rd, and Martinez, F.J. (2004). Mechanisms of pulmonary fibrosis. Annu Rev Med 55, 395-417. doi: 10.1146/annurev.med.55.091902.103810.
164. Thiery, J.P., Acloque, H., Huang, R.Y., and Nieto, M.A. (2009). Epithelial1169 mesenchymal transitions in development and disease. Cell 139, 871-890. doi: 10.1016/j.cell.2009.11.007.
165. Tietze, L., Elbrecht, A., Schauerte, C., Klosterhalfen, B., Amo-Takyi, B., Gehlen, J., Winkeltau, G., Mittermayer, C., and Handt, S. (1998). Modulation of pro1173 and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL-1beta). Thromb Haemost 79, 362-370.
166. Tomino, Y. (2012). Mechanisms and interventions in peritoneal fibrosis. Clin Exp Nephrol. 2012 Feb;16(1):109-14. doi: 10.1007/s10157-011-0533-y. Epub 2011 Sep 21.
167. Tong, M., Wang, Y., Wang, Y., Chen, H., Wang, C., Yang, L., Axelsson, J., and Lindholm, B. (2012). Genistein attenuates advanced glycation end product1181 induced expression of fibronectin and connective tissue growth factor. Am J Nephrol 36, 34-40. doi: 10.1159/000339168.
168. Topley, N. (1998). Membrane longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions. Adv Ren Replace Ther. 1998 Jul;5(3):179-84.
169. Topley, N., Petersen, M.M., Mackenzie, R., Neubauer, A., Stylianou, E., Kaever, V., Davies, M., Coles, G.A., Jorres, A., and Williams, J.D. (1994). Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int 46, 900-909.
170. Trochsler, M., and Maddern, G.J. (2014). Adhesion barriers for abdominal surgery: a sticky problem. Lancet 383, 8-10. doi: 10.1016/S0140-6736(13)62002-4.
171. Ueno, T., Nakashima, A., Doi, S., Kawamoto, T., Honda, K., Yokoyama, Y., Doi, T., Higashi, Y., Yorioka, N., Kato, Y., Kohno, N., and Masaki, T. (2013). Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta1 signaling. Kidney Int 84, 297-307. doi: 10.1038/ki.2013.81.
172. Van Grevenstein, W.M., Hofland, L.J., Van Rossen, M.E., Van Koetsveld, P.M., Jeekel, J., and Van Eijck, C.H. (2007). Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers. Dig Dis Sci 52, 2775-2783. doi: 10.1007/s10620-007-9778-4.
173. Van Tuyn, J., Atsma, D.E., Winter, E.M., Van Der Velde-Van Dijke, I., Pijnappels, D.A., Bax, N.A., Knaan-Shanzer, S., Gittenberger-De Groot, A.C., Poelmann, R.E., Van Der Laarse, A., Van Der Wall, E.E., Schalij, M.J., and De Vries, A.A. (2007). Epicardial cells of human adults can undergo an epithelial-to1205 mesenchymal transition and obtain characteristics of smooth muscle cells in vitro. Stem Cells 25, 271-278. doi: 10.1634/stemcells.2006-0366.
174. Verco, S.J., Peers, E.M., Brown, C.B., Rodgers, K.E., Roda, N., and Dizerega, G. (2000). Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: pre-clinical studies. Hum Reprod 15, 1764-1772.
175. Verger, C., Luger, A., Moore, H.L., and Nolph, K.D. (1983). Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury. Kidney Int. 1983 Jun;23(6):823-31.
176. Wada, A.M., Smith, T.K., Osler, M.E., Reese, D.E., and Bader, D.M. (2003). Epicardial/Mesothelial cell line retains vasculogenic potential of embryonic epicardium. Circ Res 92, 525-531. doi: 10.1161/01.RES.0000060484.11032.0B.
177. Wang, N., Li, Q., Zhang, L., Lin, H., Hu, J., Li, D., Shi, S., Cui, S., Zhou, J., Ji, J., Wan, J., Cai, G., and Chen, X. (2012). Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6. PLoS One 7, e43768. doi: 10.1371/journal.pone.0043768.
178. Williams, J.D., Craig, K.J., Topley, N., Von Ruhland, C., Fallon, M., Newman, G.R., Mackenzie, R.K., and Williams, G.T. (2002). Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002 Feb;13(2):470-9.
179. Williams, J.D., Craig, K.J., Topley, N., and Williams, G.T. (2003). Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl. 2003 May;(84):S158-61.
180. Wilm, B., Ipenberg, A., Hastie, N.D., Burch, J.B., and Bader, D.M. (2005). The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development 132, 5317-5328. doi: 10.1242/dev.02141.
181. Witowski, J., Wisniewska, J., Korybalska, K., Bender, T.O., Breborowicz, A., Gahl, G.M., Frei, U., Passlick-Deetjen, J., and Jorres, A. (2001). Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol. 2001 Nov;12(11):2434-41.
182. Xiao, L., Sun, L., Liu, F.Y., Peng, Y.M., and Duan, S.B. (2010). Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells. Ther Apher Dial 14, 27-34. doi: 10.1111/j.1744-9987.2009.00701.x.
183. Yanez-Mo, M., Lara-Pezzi, E., Selgas, R., Ramirez-Huesca, M., Dominguez-Jimenez, C., Jimenez-Heffernan, J.A., Aguilera, A., Sanchez-Tomero, J.A., Bajo, M.A., Alvarez, V., Castro, M.A., Del Peso, G., Cirujeda, A., Gamallo, C., Sanchez-Madrid, F., and Lopez-Cabrera, M. (2003). Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 348, 403-413. doi: 10.1056/NEJMoa020809.
184. Yang, A.H., Chen, J.Y., and Lin, J.K. (2003). Myofibroblastic conversion of mesothelial cells. Kidney Int 63, 1530-1539. doi: 10.1046/j.1523-1755.2003.00861.x.
185. Yoshida, E., Tsuchiya, K., Sugiki, M., Sumi, H., Mihara, H., and Maruyama, M. (1996). Modulation of the receptor for urokinase-type plasminogen activator in macrophage-like U937 cells by inflammatory mediators. Inflammation 20, 319-326.
186. Yung, S., and Chan, T.M. (2007). Hyaluronan-regulator and initiator of peritoneal inflammation and remodeling. Int J Artif Organs. 2007 Jun;30(6):477-83.
187. Yung, S., and Chan, T.M. (2009). INTRINSIC CELLS: MESOTHELIAL CELLS â" CENTRAL PLAYERS IN REGULATING INFLAMMATION AND RESOLUTION. Peritoneal Dialysis International 29, S21-S27.
188. Yung, S., and Chan, T.M. (2012). Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells. Mediators Inflamm 2012, 484167. doi: 10.1155/2012/484167.
189. Yung, S., Chen, X.R., Tsang, R.C., Zhang, Q., and Chan, T.M. (2004). Reduction of perlecan synthesis and induction of TGF-beta1 in human peritoneal mesothelial cells due to high dialysate glucose concentration: implication in peritoneal dialysis. J Am Soc Nephrol. 2004 May;15(5):1178-88.
190. Yung, S., Coles, G.A., and Davies, M. (1996). IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD. Kidney Int. 1996 Oct;50(4):1337-43.
191. Yung, S., Coles, G.A., Williams, J.D., and Davies, M. (1994). The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int. 1994 Aug;46(2):527-33.
192. Yung, S., Hausser, H., Thomas, G., Schaefer, L., Kresse, H., and Davies, M. (2007). Catabolism of newly synthesized decorin in vitro by human peritoneal mesothelial cells. Perit Dial Int. 2004 Mar-Apr;24(2):147-55.
193. Yung, S., Liu, Z.H., Lai, K.N., Li, L.S., and Chan, T.M. (2001). Emodin ameliorates glucose-induced morphologic abnormalities and synthesis of transforming growth factor beta1 and fibronectin by human peritoneal mesothelial cells. Perit Dial Int 21 Suppl 3, S41-47.
194. Yung, S., Thomas, G.J., and Davies, M. (2000). Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int 58, 1953-1962. doi: 10.1111/j.1523-1755.2000.00367.x.
195. Yung, S., Thomas, G.J., Stylianou, E., Williams, J.D., Coles, G.A., and Davies, M. (1995). Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Am J Pathol 146, 520-529.
196. Zeisberg, M., and Kalluri, R. (2004). The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med (Berl) 82, 175-181. doi: 10.1007/s00109-003-0517-9.
197. Zeisberg, M., and Neilson, E.G. (2009). Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119, 1429-1437. doi: 10.1172/JCI36183.
198. Zhang, H., Liu, F.Y., Liu, Y.H., Peng, Y.M., Liao, Q., and Zhang, K. (2005). Effect of TGF-beta1 Stimulation on the Smad Signal Transduction Pathway of Human Peritoneal Mesothelial Cells. Int J Biomed Sci 1, 8-15.
199. Zhang, K., Zhang, H., Zhou, X., Tang, W.B., Xiao, L., Liu, Y.H., Liu, H., Peng, Y.M., Sun, L., and Liu, F.Y. (2012). miRNA589 regulates epithelial1295 mesenchymal transition in human peritoneal mesothelial cells. J Biomed Biotechnol 2012, 673096. doi: 10.1155/2012/673096.
200. Zhang, L., Liu, F., Peng, Y., Sun, L., and Chen, G. (2013). Changes in expression of four molecular marker proteins and one microRNA in mesothelial cells of the peritoneal dialysate effluent fluid of peritoneal dialysis patients. Exp Ther Med. 2013 Nov;6(5):1189-1193. Epub 2013 Sep 2.
201. Zhang, L., Liu, J., Liu, Y., Xu, Y., Zhao, X., Qian, J., Sun, B., and Xing, C. (2014). Fluvastatin inhibits the expression of fibronectin in human peritoneal mesothelial cells induced by high-glucose peritoneal dialysis solution via SGK1 pathway. Clin Exp Nephrol. doi: 10.1007/s10157-014-0991-0.
202. Zhou, B., Ma, Q., Rajagopal, S., Wu, S.M., Domian, I., Rivera-Feliciano, J., Jiang, D., Von Gise, A., Ikeda, S., Chien, K.R., and Pu, W.T. (2008). Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454, 109-113. doi: 10.1038/nature07060.
203. Zhou, B., Von Gise, A., Ma, Q., Hu, Y.W., and Pu, W.T. (2010). Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart. Dev Biol 338, 251-261. doi: 10.1016/j.ydbio.2009.12.007.
204. Zhou, Q., Yang, M., Lan, H., and Yu, X. (2013). miR-30a negatively regulates TGF1314 beta1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1. Am J Pathol. 2013 Sep;183(3):808-19. doi: 10.1016/j.ajpath.2013.05.019. Epub 2013 Jul 3.
205. Zolak, J.S., Jagirdar, R., Surolia, R., Karki, S., Oliva, O., Hock, T., Guroji, P., Ding, Q., Liu, R.M., Bolisetty, S., Agarwal, A., Thannickal, V.J., and Antony, V.B. (2013). Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury. Am J Pathol 182, 1239-1247. doi: 10.1016/j.ajpath.2012.12.030.